These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 11721775)

  • 1. Finally: changing the natural history of chronic hepatitis C!
    Adeniji OA; Herrera JL
    Am J Gastroenterol; 2001 Nov; 96(11):3200-1. PubMed ID: 11721775
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of chronic viral hepatitis in patients with renal disease.
    Fabrizi F; Martin P; Bunnapradist S
    Gastroenterol Clin North Am; 2004 Sep; 33(3):655-70, xi. PubMed ID: 15324949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of obesity, steatosis and insulin resistance on progression and response to therapy of hepatitis C.
    Negro F; Clément S
    J Viral Hepat; 2009 Oct; 16(10):681-8. PubMed ID: 19732324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of chronic hepatitis C.
    Asselah T; Boyer N; Ripault MP; Martinot M; Marcellin P
    Minerva Gastroenterol Dietol; 2007 Mar; 53(1):9-23. PubMed ID: 17415342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B and C in children: current treatment and future strategies.
    Elisofon SA; Jonas MM
    Clin Liver Dis; 2006 Feb; 10(1):133-48, vii. PubMed ID: 16376798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of cirrhosis due to chronic hepatitis C.
    Everson GT
    J Hepatol; 2005; 42 Suppl(1):S65-74. PubMed ID: 15777574
    [No Abstract]   [Full Text] [Related]  

  • 7. Liver steatosis and antiviral therapy in chronic hepatitis C.
    Testino G; Sumberaz A
    Liver Int; 2007 Mar; 27(2):287. PubMed ID: 17311627
    [No Abstract]   [Full Text] [Related]  

  • 8. Projecting future complications of chronic hepatitis C in the United States.
    Davis GL; Albright JE; Cook SF; Rosenberg DM
    Liver Transpl; 2003 Apr; 9(4):331-8. PubMed ID: 12682882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural history models for hepatitis C-related liver disease: different disease progression parameters for different settings.
    Dore GJ; Freeman AJ; Law M; Kaldor JM
    Antivir Ther; 2003 Oct; 8(5):365-72. PubMed ID: 14640382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chronic hepatitis C. Treatment of special groups].
    Civeira MP
    Gastroenterol Hepatol; 2000 Feb; 23 Suppl 1():68-70. PubMed ID: 11968348
    [No Abstract]   [Full Text] [Related]  

  • 11. Skin lesions in a patient on therapy for chronic hepatitis C.
    Hisamuddin K; Veluru C; Mullen KD
    Clin Gastroenterol Hepatol; 2009 Jun; 7(6):A24. PubMed ID: 19166978
    [No Abstract]   [Full Text] [Related]  

  • 12. Chronic hepatitis C in the human immunodeficiency virus-infected patient: management strategies.
    Bhattacharya D; Imperial JC; Keeffe EB
    Clin Gastroenterol Hepatol; 2006 Mar; 4(3):288-92. PubMed ID: 16527689
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of hepatitis C virus-related systemic vasculitis.
    Cacoub P; Saadoun D; Sene D; Limal N; Piette JC
    J Rheumatol; 2005 Nov; 32(11):2078-82. PubMed ID: 16265682
    [No Abstract]   [Full Text] [Related]  

  • 14. Guideline watch. New guidelines on treating chronic hepatitis B and C in HIV-coinfected patients.
    Gandhi RT
    AIDS Clin Care; 2005 Jul; 17(7):65. PubMed ID: 16110574
    [No Abstract]   [Full Text] [Related]  

  • 15. [Management of chronic viral hepatitis].
    Pache I; Mondada D; Moradpour D; Fontana M
    Rev Med Suisse; 2007 Jan; 3(95):215, 217-8, 221-3. PubMed ID: 17357690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of chronic hepatitis C virus infection: we must target the virus or liver fibrosis?
    Soriano V; Martín-Carbonero L; García-Samaniego J
    AIDS; 2003 Mar; 17(5):751-3. PubMed ID: 12646800
    [No Abstract]   [Full Text] [Related]  

  • 17. [Management of HCV-HIV patients].
    Pol S; Cacoub P; Pialoux G; Benhamou Y; Halfon P; Rosenthal E; Perronne C
    Gastroenterol Clin Biol; 2007; 31(8-9 Pt 3):4S7-12. PubMed ID: 17965629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma after a sustained response to interferon therapy.
    Basso M; Torre F; Picciotto A
    Cancer; 2005 Jun; 103(12):2654-5; author reply 2655. PubMed ID: 15884032
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of chronic hepatitis C in hemophilic patients.
    Husa P; Smejkal P; Husová L; Penka M
    Acta Virol; 2004; 48(1):35-8. PubMed ID: 15230473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of effectively treated chronic hepatitis C infection in the development of type 2 diabetes mellitus.
    Purnak T
    Hepatology; 2009 Jun; 49(6):2131-2; author reply 2132. PubMed ID: 19437495
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.